Ananda Pharma (AQSE:ANA) Total Operating Expense: £4.40 Mil (TTM As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma Total Operating Expense?

Ananda Pharma AQSE:ANA +14.58% Total Operating Expense is £4.40 Mil as of Jul. 2025. The stock has 5 warning signs investors should review.

Ananda Pharma's Total Operating Expense for the six months ended in Jul. 2025 was £1.90 Mil. Ananda Pharma's Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2025 was £4.40 Mil.

Ananda Pharma Total Operating Expense Related Terms

Ananda Pharma Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Total Operating Expense Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Total Operating Expense
Get a 7-Day Free Trial 0.50 0.97 1.05 6.79 3.57

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 5.85 1.07 2.50 1.90

Ananda Pharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £4.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of £4.40 Mil mean?
Ananda Pharma (AQSE:ANA) has a Total Operating Expense of £4.40 Mil as of Jul. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ananda Pharma and its competitors.
Is Ananda Pharma's Total Operating Expense too high?
Ananda Pharma's current Total Operating Expense is £4.40 Mil.
How does Ananda Pharma's Total Operating Expense compare to ZTS and UTHR?
Ananda Pharma's Total Operating Expense of £4.40 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Ananda Pharma and its competitors. Ananda Pharma's current Total Operating Expense is £4.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (AQSE:ANA) has a current Total Operating Expense of £4.40 Mil. The current Total Operating Expense is £4.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Ananda Pharma (AQSE:ANA), the current Total Operating Expense is £4.40 Mil as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ananda Pharma Business Description

Other Exchanges 1FX:Germany
Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).